Normal
15th March 2022

2nd Annual MarketsandMarkets Liquid Biopsy Virtual Conference [Time Zone - Eastern Standard Time (EST)]

The advancement of delicate CTC and cfDNA identification led to innovations that has empowered the improvement of liquid biopsies with numerous clinical applications, including-screening for nearness of disease, patient stratification and treatment determination,monitoring treatment reaction and early diagnostics.

MarketsandMarkets 2nd Annual Liquid Biopsy Virtual Conference will unite the pioneers from Diagnostics organization, Experts from Pharmaceutical and Bio-Pharma companies, Researchers and professors from renowned universities to address the challenges in early
detection of tumor cells and the potential of liquid biopsies to screen, monitor and treatment of the diseases.

WHAT TO EXPECT
Key Highlights
  • Identification of circulating biomarkers for early diagnosis
  • Incorporation of Artificial intelligence and machine learning in liquid biopsy
  • Challenges and advantages to the end users
  • Advancement in treatment and monitoring of cancer
  • Clinical and non-clinical application of liquid biopsy
  • Recent developments in assays for liquid biopsy
Who Should Attend?

1)Hospitals/Universities/Labs: Hospitals - Diagnostics Department, Department of clinical oncology, Pathology Labs
-Designation - Oncologist, Immunologist, Hematologist, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors
• Universities -Designation - Professors, Researchers, Associate professors in Cancer study
2) Pharma/Therapeutics: Designation - CEO, COO, Senior scientist in cancer and immunology, Research scientist in cancer, Personalized medicine individuals

Why attend?
  • Best networking opportunities with the industrial experts from all around the world
  • 100+ experts attending
  • Interactive panel discussions with pioneers of the field
  • Platform to showcase/exhibit the innovative technologies
  • Expand on existing organizations and make new connections with across industry and the scholarly community
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Speakers
Matt Davis

Matt Davis

Director, Molecular biology and Sequencing
Gritstone Oncology, Inc.

Matt Davis

Director, Molecular biology and Sequencing
Gritstone Oncology, Inc.
Dr. Harsha Doddihal

Dr. Harsha Doddihal

Clinical researcher, Oncologist
Fortis Hospital

Dr. Harsha Doddihal

Clinical researcher, Oncologist
Fortis Hospital
Dana E. Connors

Dana E. Connors

Senior Scientific Project Manager
Cancer Foundation for the National Institutes of Health

Dana E. Connors

Senior Scientific Project Manager
Cancer Foundation for the National Institutes of Health
Emmanouil Karteris

Emmanouil Karteris

Head of CBCEL
Brunel University London, UK

Emmanouil Karteris

Head of CBCEL
Brunel University London, UK
Youhe Gao

Youhe Gao

Professor Department of Biochemistry and Molecular Biology
Beijing Normal University

Youhe Gao

Professor Department of Biochemistry and Molecular Biology
Beijing Normal University
John Yahya Elshimali

John Yahya Elshimali

Associate Professor of Pathology
Charles Drew University and UCLA David Geffen School of Medicine

John Yahya Elshimali

Associate Professor of Pathology
Charles Drew University and UCLA David Geffen School of Medicine
Azeet Narayan

Azeet Narayan

Principal Scientist
Sema4 Holdings Corps, USA

Azeet Narayan

Principal Scientist
Sema4 Holdings Corps, USA
PAST EVENT GALLERY